Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways

Anti-CD20 treatment in Primary Sjögren’s Syndrome

(2010) K. Isaksen et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

(2008) G. Salles et al.   BLOOD

Use of rituximab in diffuse large B-cell lymphoma in the salvage setting

(2008) Christian Gisselbrecht   BRITISH JOURNAL OF HAEMATOLOGY

Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels

(2008) M. S. Czuczman et al.   CLINICAL CANCER RESEARCH

Update on Treatment Recommendations From the Fourth International Workshop on Waldenström's Macroglobulinemia

(2008) Meletios Athanasios Dimopoulos et al.   JOURNAL OF CLINICAL ONCOLOGY

A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases

(2008) Manuel Ramos-Casals et al.   MEDICINE

Efficacy of Biologicals in the Treatment of Rheumatoid Arthritis

(2008) S.P. Venkateshan et al.   PHARMACOLOGY

Therapeutic Potential for B-Cell Modulation in Sjögren's Syndrome

(2008) Xavier Mariette   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Targeted Treatment and New Agents in Diffuse Large B-Cell Lymphoma

(2008) John P. Leonard et al.   SEMINARS IN HEMATOLOGY